GURUFOCUS.COM » STOCK LIST » Financial Services » Diversified Financial Services » Orion Biotech Opportunities Corp (OTCPK:ORIAW) » Definitions » Market Cap

Orion Biotech Opportunities (Orion Biotech Opportunities) Market Cap : $0.00 Mil (As of Jun. 18, 2024)


View and export this data going back to 2021. Start your Free Trial

What is Orion Biotech Opportunities Market Cap?

Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Orion Biotech Opportunities's share price for the quarter that ended in Dec. 2022 was $0. Orion Biotech Opportunities's Shares Outstanding (EOP) for the quarter that ended in Dec. 2022 was 0.00 Mil. Therefore, Orion Biotech Opportunities's market cap for the quarter that ended in Dec. 2022 was $ Mil.

Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Orion Biotech Opportunities's Enterprise Value for Today is $0.00 Mil.


Orion Biotech Opportunities Market Cap Historical Data

The historical data trend for Orion Biotech Opportunities's Market Cap can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Orion Biotech Opportunities Market Cap Chart

Orion Biotech Opportunities Annual Data
Trend Dec21 Dec22
Market Cap
- -

Orion Biotech Opportunities Quarterly Data
Feb21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22
Market Cap Get a 7-Day Free Trial - - - - -

Competitive Comparison of Orion Biotech Opportunities's Market Cap

For the Shell Companies subindustry, Orion Biotech Opportunities's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Orion Biotech Opportunities's Market Cap Distribution in the Diversified Financial Services Industry

For the Diversified Financial Services industry and Financial Services sector, Orion Biotech Opportunities's Market Cap distribution charts can be found below:

* The bar in red indicates where Orion Biotech Opportunities's Market Cap falls into.



Orion Biotech Opportunities Market Cap Calculation

Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.

Orion Biotech Opportunities's Market Cap for the fiscal year that ended in Dec. 2022 is calculated as

Market Cap (A: Dec. 2022 )=Share Price (A: Dec. 2022 )*Shares Outstanding (EOP) (A: Dec. 2022 )
=$0*0
=$

Orion Biotech Opportunities's Market Cap for the quarter that ended in Dec. 2022 is calculated as

Market Cap (Q: Dec. 2022 )=Share Price (Q: Dec. 2022 )*Shares Outstanding (EOP) (Q: Dec. 2022 )
=$0*0
=$

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Orion Biotech Opportunities  (OTCPK:ORIAW) Market Cap Explanation

Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the company’s debt. The real price you pay is the Enterprise Value.

Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.


Orion Biotech Opportunities Market Cap Related Terms

Thank you for viewing the detailed overview of Orion Biotech Opportunities's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.


Orion Biotech Opportunities (Orion Biotech Opportunities) Business Description

Traded in Other Exchanges
N/A
Address
One Vanderbilt Avenue, 26th Floor, New York, NY, USA, 10017
Orion Biotech Opportunities Corp is a blank check company.